Guidance Issued for ‘Extremely Vulnerable’ People

The government has issued guidance today for people they consider to be 'extremely vulnerable'. It gives details of how they should protect themselves from COVID-19.

Definition of 'Extremely Vulnerable' as at 22 March 2020 (today):

The government says that people falling into this extremely vulnerable group include:

  1. Solid organ transplant recipients
  2. People with specific cancers:
    • people with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    • people having immunotherapy or other continuing antibody treatments for cancer
    • people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    • people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
  3. People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe COPD.
  4. People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell).
  5. People on immunosuppression therapies sufficient to significantly increase risk of infection.
  6. Women who are pregnant with significant heart disease, congenital or acquired.

People affected will be contacted directly by the NHS.

Latest Information

PLEASE SEE OUR PSC AND COVID-19 SUMMARY - REGULARLY UPDATED

Other COVID-19 News

PSC and COVID-19 FAQs

23 Mar 2020

We’ve put together the information you are asking for on our helpline and Facebook group: social distancing, shielding, vulnerable groups.

Read More

COVID-19 Webinar

21 Mar 2020

Watch a webinar about PSC/IBD and COVID-19

Read More

Letter from the Rare Liver ERN

18 Mar 2020

Reassuring update from Professor Ansgar Lohse, coordinator of the RARE LIVER ERN and specialist both in Hepatology and in infectious diseases

Read More

COVID-19 and PSC

17 Mar 2020

Important information about PSC and acute cholangitis planning.

Read More

COVID-19 Latest Update

16 Mar 2020

New guidance, ‘vulnerable’ people, social distancing information.

Read More

Inflammatory Bowel Disease and COVID-19

10 Mar 2020

The current COVID-19 recommendations for people with IBD.

Read More

Coronavirus Information

14 Feb 2020

UPDATED 13 Mar 2020 The latest COVID-19 guidance – updated regularly.

Read More